JAAD Study Examines Biologic Safety in Psoriasis Patients With Malignancy
A November 2026 JAAD analysis by Lin, Ho, and Wu examines whether biologic therapy is safe for psoriasis patients with current or prior malignancy — a population pivotal trials exclude.